177 related articles for article (PubMed ID: 19788915)
1. Repeated antidepressant therapy increases cyclic GMP signaling in rat hippocampus.
Reierson GW; Mastronardi CA; Licinio J; Wong ML
Neurosci Lett; 2009 Dec; 466(3):149-53. PubMed ID: 19788915
[TBL] [Abstract][Full Text] [Related]
2. Chronic imipramine downregulates cyclic AMP signaling in rat hippocampus.
Reierson GW; Mastronardi CA; Licinio J; Wong ML
Neuroreport; 2009 Feb; 20(3):307-11. PubMed ID: 19444954
[TBL] [Abstract][Full Text] [Related]
3. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
Suvarna NU; O'Donnell JM
J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
[TBL] [Abstract][Full Text] [Related]
4. Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2016 Feb; 91():215-27. PubMed ID: 26773602
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice.
Wang C; Zhang J; Lu Y; Lin P; Pan T; Zhao X; Liu A; Wang Q; Zhou W; Zhang HT
Metab Brain Dis; 2014 Sep; 29(3):673-82. PubMed ID: 24705918
[TBL] [Abstract][Full Text] [Related]
6. Regulation of intracellular cyclic GMP levels in olfactory sensory neurons.
Moon C; Simpson PJ; Tu Y; Cho H; Ronnett GV
J Neurochem; 2005 Oct; 95(1):200-9. PubMed ID: 16181424
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex.
Sutor B; Mantell K; Bacher B
Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358
[TBL] [Abstract][Full Text] [Related]
8. Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration.
D'Sa C; Eisch AJ; Bolger GB; Duman RS
Eur J Neurosci; 2005 Sep; 22(6):1463-75. PubMed ID: 16190900
[TBL] [Abstract][Full Text] [Related]
9. Hydrolysis of cyclic guanosine monophosphate and cyclic adenosine monophosphate by the penis and aorta of the diabetic rat.
Miller MA; Morgan RJ; Thompson CS; Mikhailidis DP; Jeremy JY
Br J Urol; 1996 Aug; 78(2):252-6. PubMed ID: 8813923
[TBL] [Abstract][Full Text] [Related]
10. Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain.
Kelly MP
Cell Signal; 2018 Jan; 42():281-291. PubMed ID: 29175000
[TBL] [Abstract][Full Text] [Related]
11. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide.
Bellamy TC; Garthwaite J
Mol Pharmacol; 2001 Jan; 59(1):54-61. PubMed ID: 11125024
[TBL] [Abstract][Full Text] [Related]
12. The perspective of cAMP/cGMP signaling and cyclic nucleotide phosphodiesterases in aortic aneurysm and dissection.
Shu T; Zhou Y; Yan C
Vascul Pharmacol; 2024 Mar; 154():107278. PubMed ID: 38262506
[TBL] [Abstract][Full Text] [Related]
13. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
Zhao CY; Greenstein JL; Winslow RL
J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant-like effect of Wuling mycelia powder in rat.
Tan YF; Liao ZL; Qiu YJ; Zhu JP; Yu EY
Biomed Pharmacother; 2016 Mar; 78():60-65. PubMed ID: 26898425
[TBL] [Abstract][Full Text] [Related]
15. Phosphodiesterase genes and antidepressant treatment response: a review.
Esposito K; Reierson GW; Luo HR; Wu GS; Licinio J; Wong ML
Ann Med; 2009; 41(3):177-85. PubMed ID: 18932104
[TBL] [Abstract][Full Text] [Related]
16. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study.
Oelke M; Hedlund P; Albrecht K; Ellinghaus P; Stief CG; Jonas U; Andersson KE; Uckert S
Urology; 2006 May; 67(5):1111-6. PubMed ID: 16635522
[TBL] [Abstract][Full Text] [Related]
17. Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.
Guo L; Luo L; Ju R; Chen C; Zhu L; Li J; Yu X; Ye C; Zhang D
Eur J Pharmacol; 2015 Jan; 746():14-21. PubMed ID: 25446933
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide phosphodiesterases in rabbit detrusor smooth muscle.
Qiu Y; Kraft P; Craig EC; Liu X; Haynes-Johnson D
Urology; 2002 Jan; 59(1):145-9. PubMed ID: 11796312
[TBL] [Abstract][Full Text] [Related]
19. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
[TBL] [Abstract][Full Text] [Related]
20. Sequential alterations in the hepatic content and metabolism of cyclic AMP and cyclic GMP induced by DL-ethionine: evidence for malignant transformation of liver with a sustained increase in cyclic AMP.
DeRubertis FR; Craven PA
Metabolism; 1976 Dec; 25(12):1611-25. PubMed ID: 186692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
